Want to create interactive content? It’s easy in Genially!

Get started free

[MS-0023] CS_EMD Serono_Treatments for Relapsing MS

MyHealthTeam

Created on June 9, 2025

Start designing with a free template

Discover more than 1500 professional designs like these:

Customer Profile

Movie Infographic

Interactive QR Code Generator

Advent Calendar

Tree of Wishes

Witchcraft vertical Infographic

Halloween Horizontal Infographic

Transcript

DMTs for Relapsing Forms of Multiple Sclerosis

VIEW ALL

ORAL

INFUSION

INJECTION

Alemtuzumab (Lemtrada)

Five days in a row, then three days one year later

Cladribine (Mavenclad)

10 pills in year one, 10 pills in year two

Dimethyl fumarate (Tecfidera)

Twice a day

Diroximel fumarate (Vumerity)

Fingolimod (Gilenya)

Twice a day

Once a day

Glatiramer acetate (Copaxone)

Daily or three times a week

Interferon beta-1b (Betaseron)

Every other day

Interferon beta-1a (Avonex)

Interferon beta-1a (Rebif)

Once a week

Three times a week

Interferon beta-1b (Extavia)

Natalizumab (Tysabri)

Every other day

Monthly

Monomethyl fumarate (Bafiertam)

Twice a day

Ocrelizumab (Ocrevus)

Ofatumumab (Kesimpta)

Every six months

Monthly

Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)a

Twice a year

Ponesimod (Ponvory)

Once a day

Ozanimod (Zeposia)

Once a day

Peginterferon beta-1a (Plegridy)

Every two weeks

Ublituximab (Briumvi)

2.5-hour IV infusion every six months

Siponimod (Mayzent)

Once a day

Teriflunomide (Aubagio)

Once a day

aBased on information sourced from “FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis SocietyBased on information sourced from “Treatment for MS” provided by MS Focus

DMTs for Relapsing Forms of Multiple Sclerosis

VIEW ALL

ORAL

INFUSION

INJECTION

Ocrelizumab (Ocrevus)

Natalizumab (Tysabri)

Monthly

Every six months

Alemtuzumab (Lemtrada)

Five days in a row, then three days one year later

Ublituximab (Briumvi)

2.5-hour IV infusion every six months

aBased on information sourced from “FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis SocietyBased on information sourced from “Treatment for MS” provided by MS Focus

DMTs for Relapsing Forms of Multiple Sclerosis

VIEW ALL

ORAL

INFUSION

INJECTION

Diroximel fumarate (Vumerity)

Cladribine (Mavenclad)

10 pills in year one, 10 pills in year two

Twice a day

Dimethyl fumarate (Tecfidera)

Twice a day

Ozanimod (Zeposia)

Once a day

Fingolimod (Gilenya)

Monomethyl fumarate (Bafiertam)

Once a day

Twice a day

Siponimod (Mayzent)

Ponesimod (Ponvory)

Once a day

Once a day

Teriflunomide (Aubagio)

Once a day

aBased on information sourced from “FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis SocietyBased on information sourced from “Treatment for MS” provided by MS Focus

DMTs for Relapsing Forms of Multiple Sclerosis

VIEW ALL

ORAL

INFUSION

INJECTION

Interferon beta-1a (Avonex)

Glatiramer acetate (Copaxone)

Interferon beta-1a (Rebif)

Daily or three times a week

Once a week

Three times a week

Interferon beta-1b (Betaseron)

Every other day

Interferon beta-1b (Extavia)

Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)a

Every other day

Twice a year

Ofatumumab (Kesimpta)

Peginterferon beta-1a (Plegridy)

Monthly

Every two weeks

aBased on information sourced from “FDA Approves Ocrevus Zunovo (Ocrelizumab & Hyaluronidase-Ocsq), Similar to Ocrevus” provided by National Multiple Sclerosis SocietyBased on information sourced from “Treatment for MS” provided by MS Focus